EMD Serono
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Bavencio | Avelumab | 2017-03-23 | ||
| Cetrotide | Cetrorelix | 2000-08-11 | ||
| Geref | Sermorelin | 1990-12-28 | ||
| Glucophage | Metformin | 1995-03-03 | 2023-2035 | |
| Gonal-f | Follitropin alfa | 1997-09-29 | ||
| Gonal-f rff | Follitropin alfa | 2004-03-25 | ||
| Gonal-f rff rediject | Follitropin alfa | 2004-05-25 | ||
| Mavenclad | Cladribine | 2019-03-29 | 2024-2038 | |
| Novantrone | Mitoxantrone | 1987-12-23 | ||
| Ovidrel | Choriogonadotropin alfa | 2000-09-20 | ||
| Pergonal | Menotropins | 1975-08-22 | — | |
| Raptiva | Efalizumab | 2004-09-20 | ||
| Rebif | Interferon beta-1a | 2002-03-07 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use